Directory
>
Erica Rappold
Erica Rappold
Safety Surveillance Manager, Women's Healthcare Division | Incyte
Pennsylvania, Philadelphia, United States
Erica Rappold
Summary
Erica Rappold is an accomplished Executive Director in Clinical Development at Incyte, specializing in oncology and clinical trials. With over two decades of experience in the pharmaceutical industry, she has held significant roles at major companies such as Eli Lilly and GSK, where she led critical clinical investigations and contributed to regulatory submissions. Erica's expertise encompasses clinical research, safety surveillance, and scientific communications, making her a key player in advancing cancer treatment. Her educational background in nursing from Hahnemann University complements her clinical insights with a strong foundation in patient care. Erica is known for her strategic leadership in managing teams and projects, particularly in high-stakes environments. She is passionate about innovation in healthcare and the impact of clinical research on patient outcomes. Erica's career reflects a commitment to excellence and a deep understanding of the complexities of drug development.
Erica Rappold
Work Experience
Executive Director, Clinical Research Scientist at
Incyte
January 2017 - Present
Erica Rappold
Education
Hahnemann University, BSN, Registered Nursing/Registered Nurse
January 1987 - January 1991
Frequently Asked Questions about Erica Rappold
What is Erica Rappold email address?
Erica Rappold's primary email address is *************@adaptimmune.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Erica Rappold work for?
Erica Rappold is a Safety Surveillance Manager, Women's Healthcare Division at Incyte.
Where Erica Rappold graduated from?
Erica Rappold holds a degree in null from Hahnemann University.
How can I directly contact Erica Rappold?
To contact Erica Rappold directly, you can use the email address *************@adaptimmune.com. Complete contact information is available upon registration with Muraena.
Who is Erica Rappold?
Erica Rappold is an accomplished Executive Director in Clinical Development at Incyte, specializing in oncology and clinical trials. With over two decades of experience in the pharmaceutical industry, she has held significant roles at major companies such as Eli Lilly and GSK, where she led critical clinical investigations and contributed to regulatory submissions. Erica's expertise encompasses clinical research, safety surveillance, and scientific communications, making her a key player in advancing cancer treatment. Her educational background in nursing from Hahnemann University complements her clinical insights with a strong foundation in patient care. Erica is known for her strategic leadership in managing teams and projects, particularly in high-stakes environments. She is passionate about innovation in healthcare and the impact of clinical research on patient outcomes. Erica's career reflects a commitment to excellence and a deep understanding of the complexities of drug development.
Erica`s contact details
*************@adaptimmune.com
********@incyte.com
Colleagues
Various
Comprehensive Ophthalmologist
Postdoctoral Fellow
University of Cologne, Germany, Department I of Internal Medicine
Lead Clinical Research Associate (I, II, Lead)
Sales Rep Primary Care
Post-doc Research Fellow
Associate Professor of Pediatrics, Hematology/Oncology
Clinical Associate in Pediatrics